HUABIO Blog

Tau dysfunction is a defining feature of Alzheimer’s disease, frontotemporal dementia (FTD), and other tauopathies, where changes in aggregation, isoform expression, and phosphorylation contribute to neurodegeneration. Discover how researchers use tau-specific and phospho-tau antibodies to investigate disease mechanisms and distinguish between closely related neurodegenerative disorders.

Tau is a critical regulator of microtubule stability in neurons, yet its dysregulation is linked to more than 26 neurodegenerative diseases. Understanding the differences between total tau and phospho-tau provides valuable insight into how post-translational modifications influence tau function, aggregation, and disease progression.

Antibody formulation can directly impact experimental performance, especially in applications involving conjugation, live cells, or sensitive downstream assays. This blog breaks down the common components found in antibody formulations and explains how choosing the right formulation can improve experimental outcomes and reproducibility.

Reliable CXCL2 antibody performance in IHC is essential for studying inflammatory signaling in tissue samples and generating reproducible, biologically meaningful data.

What once seemed like a biological mystery could soon inspire innovative therapies, changing the way we fight infections and inflammatory diseases for years to come.

Introducing Huabio Nanoselectors - a fast, reliable and efficient one-step immunoprecipitation assay.